Unlocking the Potential of Baricitinib for Vitiligo

Cutis. 2024 Sep;114(3):95-96. doi: 10.12788/cutis.1093.
No abstract available

Publication types

  • Letter

MeSH terms

  • Azetidines* / administration & dosage
  • Azetidines* / therapeutic use
  • Humans
  • Janus Kinase Inhibitors / therapeutic use
  • Purines* / administration & dosage
  • Pyrazoles* / administration & dosage
  • Pyrazoles* / adverse effects
  • Sulfonamides* / administration & dosage
  • Vitiligo* / drug therapy

Substances

  • baricitinib
  • Azetidines
  • Purines
  • Sulfonamides
  • Pyrazoles
  • Janus Kinase Inhibitors